Hosted on MSN1mon
Pfizer director Ronald E. Blaylock acquires $499,072 in stock
On February 13, Ronald E. Blaylock, a director at Pfizer Inc. (NYSE:PFE), purchased 19,457 shares of the company's common stock. The transaction was valued at a total of $499,072, with each share ...
Hosted on MSN1mon
CarMax updates bylaws and director Blaylock to exit board
CarMax Inc . (NYSE:KMX), currently valued at $13.19 billion, announced on Monday that Ronald E. Blaylock, a member of its board of directors, will not seek reelection at the company's upcoming ...